Short-term outcome in ischemic stroke patients after thrombolytic therapy

Short-term outcome in ischemic stroke patients after thrombolytic therapy

Abstract Background Stroke represents the second leading cause of death in the world after myocardial infarction. Intravenous (IV) thrombolysis with recombinant tissue plasminogen activator (alteplase, rt-PA) is the only pharmacological therapy that was approved for treatment within 4.5 h of acute i...

Full description

Bibliographic Details
Main Authors: Wafaa S. Mohamed, Adel S. Abdel Ghaffar, Ahmed E. Abdel Gawad, Emad L. Agban
Format: Article
Language:English
Published: SpringerOpen 2021-01-01
Series:The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Subjects:
Ischemic stroke
Thrombolytic therapy
Outcome
Online Access:https://doi.org/10.1186/s41983-020-00251-7

Similar Items

Similar Items